Search Results 1051-1060 of 16345 for monoclonal antibody
... monoclonal antibody-containing therapy. Note: Relapsed disease is defined as disease that has recurred ≥6 months after completion of therapy. Refractory ...
anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; an anthracycline containing chemotherapy regimen. No evidence ...
Principal proponent, Unrestricted Medical Education Grant Award for "Monoclonal antibody therapy in COVID-19" Education awarded to Mayo Clinic in ArizonaLilly ...
anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; an anthracycline containing chemotherapy regimen;; for subjects ...
It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is to be given only by or under the direct supervision of your ...
composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation
Stegall, M.D., Transplantation Surgery, Mayo Clinic: About 80 percent of people who have had a previous transplant have antibodies against other tissue types.
... antibodies. Upon pathogen challenge or immunization, the elderly often demonstrate poor germinal center production, which leads to reduced antibody generation.
... monoclonal antibody, including gemtuzumab ozogamicin, 28 days prior to the first dose of NKX101 Note: Treatment with hydroxyurea is allowed up to 48 hours ...
Contact. Contact Dr. Slager about her research on the genetic basis of chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis, or about ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.